Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stam

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
British Journal of Cancer|October 2, 2003
CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivationA G M Stam, S J A M Santegoets, T M Westers, et al.
Science Immunology|July 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T<sub>reg</sub> reduction and effector T cell activationKim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2012
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatmentSaskia J A M Santegoets, Anita G M Stam, Sinéad M Lougheed, et al.
Plos One|July 23, 2013
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiationJelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2010
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodesB J R Sluijter, M F C M van den Hout, A G M Stam, et al.
Radiology|September 8, 2016
Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE StudyHester J Scheffer, Laurien G P H Vroomen, Marcus C de Jong, et al.
The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.
The Lancet. Child & Adolescent Health|September 11, 2022
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trialFleur M Keij, René F Kornelisse, Nico G Hartwig, et al.
Nature|November 30, 2007
A dynamic upper atmosphere of Venus as revealed by VIRTIS on Venus ExpressP Drossart, G Piccioni, J C Gérard, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
British Journal of Cancer|October 2, 2003
CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivationA G M Stam, S J A M Santegoets, T M Westers, et al.
Science Immunology|July 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T<sub>reg</sub> reduction and effector T cell activationKim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2012
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatmentSaskia J A M Santegoets, Anita G M Stam, Sinéad M Lougheed, et al.
Plos One|July 23, 2013
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiationJelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2010
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodesB J R Sluijter, M F C M van den Hout, A G M Stam, et al.
Radiology|September 8, 2016
Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE StudyHester J Scheffer, Laurien G P H Vroomen, Marcus C de Jong, et al.
The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.
The Lancet. Child & Adolescent Health|September 11, 2022
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trialFleur M Keij, René F Kornelisse, Nico G Hartwig, et al.
Nature|November 30, 2007
A dynamic upper atmosphere of Venus as revealed by VIRTIS on Venus ExpressP Drossart, G Piccioni, J C Gérard, et al.
Pageof 7